<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2002 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER II - GENERAL POWERS AND DUTIES</span><br/>
<span style="font-size:10pt">Part B - Federal-State Cooperation</span><br/>
<span style="font-size:10pt">Sec. 247b-17 - Human papillomavirus</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_247b-17  usckey:420000000024700000000000b00170000 currentthrough:20030106 documentPDFPage:194 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER II/Part B/Sec. 247b-17 -->
<!-- itemsortkey:420AAHE -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER II-GENERAL POWERS AND DUTIES!@!Part B-Federal-State Cooperation!@!Sec. 247b-17 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;247b&ndash;17. Human papillomavirus</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Surveillance</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary, acting through the Centers for Disease Control and Prevention, shall&mdash;</p>
<p class="statutory-body-2em">(A) enter into cooperative agreements with States and other entities to conduct sentinel surveillance or other special studies that would determine the prevalence in various age groups and populations of specific types of human papillomavirus (referred to in this section as &ldquo;HPV&rdquo;) in different sites in various regions of the United States, through collection of special specimens for HPV using a variety of laboratory-based testing and diagnostic tools; and</p>
<p class="statutory-body-2em">(B) develop and analyze data from the HPV sentinel surveillance system described in subparagraph (A).</p>
<h4 class="paragraph-head">(2) Report</h4>
<p class="statutory-body-1em">The Secretary shall make a progress report to the Congress with respect to paragraph (1) no later than 1 year after the effective date of this section.</p>
<h4 class="subsection-head">(b) Prevention activities; education program</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary, acting through the Centers for Disease Control and Prevention, shall conduct prevention research on HPV, including&mdash;</p>
<p class="statutory-body-2em">(A) behavioral and other research on the impact of HPV-related diagnosis on individuals;</p>
<p class="statutory-body-2em">(B) formative research to assist with the development of educational messages and information for the public, for patients, and for their partners about HPV;</p>
<p class="statutory-body-2em">(C) surveys of physician and public knowledge, attitudes, and practices about genital HPV infection; and</p>
<p class="statutory-body-2em">(D) upon the completion of and based on the findings under subparagraphs (A) through (C), develop and disseminate educational materials for the public and health care providers regarding HPV and its impact and prevention.</p>
<h4 class="paragraph-head">(2) Report; final proposal</h4>
<p class="statutory-body-1em">The Secretary shall make a progress report to the Congress with respect to paragraph (1) not later than 1 year after the effective date of this section, and shall develop a final report not later than 3 years after such effective date, including a detailed summary of the significant findings and problems and the best strategies to prevent future infections, based on available science.</p>
<h4 class="subsection-head">(c) HPV education and prevention</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary shall prepare and distribute educational materials for health care providers and the public that include information on HPV. Such materials shall address&mdash;</p>
<p class="statutory-body-2em">(A) modes of transmission;</p>
<p class="statutory-body-2em">(B) consequences of infection, including the link between HPV and cervical cancer;</p>
<p class="statutory-body-2em">(C) the available scientific evidence on the effectiveness or lack of effectiveness of condoms in preventing infection with HPV; and</p>
<p class="statutory-body-2em">(D) the importance of regular Pap smears, and other diagnostics for early intervention and prevention of cervical cancer purposes in preventing cervical cancer.</p>
<h4 class="paragraph-head">(2) Medically accurate information</h4>
<p class="statutory-body-1em">Educational material under paragraph (1), and all other relevant educational and prevention materials prepared and printed from this date forward for the public and health care providers by the Secretary (including materials prepared through the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration), or by contractors, grantees, or subgrantees thereof, that are specifically designed to address STDs including HPV shall contain medically accurate information regarding the effectiveness or lack of effectiveness of condoms in preventing the STD the materials are designed to address. Such requirement only applies to materials mass produced for the public and health care providers, and not to routine communications.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title III, &sect;317P, as added Pub. L. 106&ndash;554, &sect;1(a)(1) [title V, &sect;516(a)], Dec. 21, 2000, 114 Stat. 2763, 2763A&ndash;72.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The effective date of this section, referred to in subsecs. (a)(2) and (b)(2), is the date of enactment of Pub. L. 106&ndash;554, which was approved Dec. 21, 2000.</p>
<!-- field-end:referenceintext-note -->
<!-- field-end:notes -->


</body></html>